ST. PAUL, Minn., April 10, 2007 (PRIME NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) announced today that it will hold a teleconference to discuss first quarter results on Tuesday, April 17, at 9:30 a.m. Central Time (10:30 a.m. Eastern). During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously. MEDTOX is scheduled to release financial results for the quarter at approximately 6:00 a.m. Central Time on April 17.
To access the teleconference, dial (877) 704-5382 ten minutes before the scheduled start time on April 17. International callers may access the call by dialing (913) 312-1296. Callers should ask for the MEDTOX quarterly conference call, hosted by Dick Braun, president and CEO of MEDTOX.
A simultaneous webcast of the conference call will be available on the MEDTOX website in the "investors" section at www.medtox.com. An audio replay of the conference call will be available through April 24 by dialing (888) 203-1112, passcode 5040573. International callers may access the replay at (719) 457-0820, with the same passcode 5040573.
MEDTOX also announced today that the Company's Annual Stockholder Meeting will be held at 3:30 p.m. Central Time on Wednesday, May 23, 2007, at the Courtyard Marriott at the Depot located at 225 Third Avenue South, Minneapolis, Minnesota. Stockholders of record as of the close of business on March 30, 2007, will be entitled to vote at the meeting or by proxy. Proxy materials will be mailed to stockholders on or around April 17, 2007.
MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices. The company also supports customers with complete logistics, data and program management services. MEDTOX is a leader in providing esoteric laboratory testing services to hospitals and laboratories nationwide. This includes both central laboratory and bio-analytical testing for pharmaceutical clinical trials. MEDTOX develops and manufactures diagnostic devices for quick and economical on-site/point-of-collection analysis for drugs-of-abuse, therapeutic drugs and biological and agricultural toxins and provides employment drug screening and occupational health testing. For more information see www.medtox.com.
The MEDTOX Scientific, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3264